Allergy/Imm

Your Article Summary

See Latest Articles

Interferon-beta Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?
Journal of Neurological Sciences (Turkish), 06/22/09

Kurne A et al. - This study evaluates the two MS subgroups that are not in the range of expected age profiles (<20 and >40 years old patients). Although increasing evidence suggests a slower disease course in children with MS when compared to adults, significant disability can still accumulate by early adulthood. There are controversial reports regarding the prognosis of late onset MS patients...In this study, the response to IFN therapy in young onset MS patients has been found similar to older age onset MS patients.

Today in Neurologic/Ophthalmic...keeping you current

Receive free subspecialty "5-minute updates" via email

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: Design and lessons from a 16-year observational study
Clinical Therapeutics, 10/16/09

The management of allergic eye diseases in primary eye care
Contact Lens and Anterior Eye, 11/03/09

Histamine, antihistamines, and the central nervous system
Allergy and Asthma Proceedings, 10/09/09

See All of Neurologic/Ophthalmic

Today in Vaccine/Immunotherapy...keeping you current

Receive free subspecialty "5-minute updates" via email

Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09

Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies
International Journal of Epidemiology, 10/14/09

Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the age of remission?
Expert Opinion on Investigational Drugs, 10/13/09

See All of Vaccine/Immunotherapy